Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Eledon Pharmaceuticals Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-12-20
Purchase
2021-12-21
4:05 pm
Eledon Pharmaceuticals Inc. ELDN Gros David-Alexandre C
CEO
2,000 $4.48 $8,960 9,000
(Direct)
View
2021-08-17
Purchase
2021-08-19
4:05 pm
Eledon Pharmaceuticals Inc. ELDN Gros David-Alexandre C
CEO
4,000 $6.21 $24,840 7,000
(Direct)
View
2021-06-11
Purchase
2021-06-14
5:24 pm
Eledon Pharmaceuticals Inc. ELDN Little Paul Sean
CFO
10,000 $8.87 $88,700 10,000
(Direct)
View
2021-06-09
Purchase
2021-06-10
5:25 pm
Eledon Pharmaceuticals Inc. ELDN Gros David-Alexandre C
CEO
3,000 $8.01 $24,030 3,000
(Direct)
View
2020-12-02
Sale
2020-12-04
5:17 pm
Novus Therapeutics Inc. NVUS OrbiMed Israel GP Ltd.
OrbiMed Israel BioFund GP Limited Partnership
10% Owner
103,200 $21.6 $2,229,120 73,650
(Indirect)
View
2020-10-30
Purchase
2020-11-06
6:46 pm
Novus Therapeutics Inc. NVUS Logos Global Management LP
10% Owner
92,040 $25.44 $2,341,714 224,071
(Indirect)
View
2020-10-30
Sale
2020-11-06
6:46 pm
Novus Therapeutics Inc. NVUS Logos Global Management LP
10% Owner
12,969 $26.64 $345,559 224,071
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-02-01
Option Award
2022-02-02
5:38 pm
N/A
2032-02-01
Eledon Pharmaceuticals Inc. ELDN Gros David-Alexandre C
CEO
108,000 $0 108,000
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:37 pm
N/A
2032-02-01
Eledon Pharmaceuticals Inc. ELDN Smith Bryan E.
General Counsel Corporate Sec
120,000 $0 120,000
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:37 pm
N/A
2032-02-01
Eledon Pharmaceuticals Inc. ELDN Perrin Steven
President
155,000 $0 155,000
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:36 pm
N/A
2032-02-01
Eledon Pharmaceuticals Inc. ELDN Ogier Walter C
Director
20,000 $0 20,000
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:35 pm
N/A
2032-02-01
Eledon Pharmaceuticals Inc. ELDN McBride John S.
Director
20,000 $0 20,000
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:33 pm
N/A
2032-02-01
Eledon Pharmaceuticals Inc. ELDN LYONS GARY A
Director
20,000 $0 20,000
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:32 pm
N/A
2032-02-01
Eledon Pharmaceuticals Inc. ELDN Lee June
Director
20,000 $0 20,000
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:30 pm
N/A
2032-02-01
Eledon Pharmaceuticals Inc. ELDN Katkin Keith
Director
20,000 $0 20,000
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:29 pm
N/A
2032-02-01
Eledon Pharmaceuticals Inc. ELDN Hillson Jan
Director
20,000 $0 20,000
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:23 pm
N/A
2032-02-01
Eledon Pharmaceuticals Inc. ELDN Little Paul Sean
CFO
155,000 $0 155,000
(Direct)
View
2022-01-20
Ownership
2022-01-31
8:52 pm
N/A
N/A
Eledon Pharmaceuticals Inc. ELDN BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
10% Owner
0 $0 11,939,402
(Direct)
View
2021-07-01
Ownership
2021-07-09
8:09 pm
N/A
2031-07-01
Eledon Pharmaceuticals Inc. ELDN Hillson Jan
Director
0 $0 40,000
(Direct)
View
2021-05-03
Option Award
2021-05-04
4:27 pm
N/A
2031-05-03
Eledon Pharmaceuticals Inc. ELDN Smith Bryan E.
See Remarks
158,500 $0 158,500
(Direct)
View
2021-03-15
Ownership
2021-03-19
07:00 am
N/A
2031-03-15
Eledon Pharmaceuticals Inc. ELDN Little Paul Sean
CFO
0 $0 160,000
(Direct)
View
2020-12-22
Conversion
2020-12-28
4:47 pm
N/A
N/A
Eledon Pharmaceuticals Inc. NVUS BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
See Explanation of Responses
1,312,841 $0 369,941
(Direct)
View
2020-12-08
Ownership
2020-12-14
4:05 pm
N/A
2030-12-08
Novus Therapeutics Inc. NVUS Lee June
Director
0 $0 40,000
(Direct)
View
2020-10-30
Ownership
2020-11-06
6:36 pm
N/A
N/A
Novus Therapeutics Inc. NVUS Logos Global Management LP
10% Owner
0 $0 1,260,722
(Indirect)
View
2020-10-01
Ownership
2020-10-05
7:53 pm
N/A
N/A
Novus Therapeutics Inc. NVUS BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
10% Owner
0 $0 7,165,667
(Direct)
View
2020-09-14
Ownership
2020-09-24
7:44 pm
N/A
2030-09-14
Novus Therapeutics Inc. NVUS Perrin Steven
See Remarks
0 $0 395,146
(Direct)
View
2020-09-14
Ownership
2020-09-24
7:44 pm
N/A
2027-08-31
Novus Therapeutics Inc. NVUS Ogier Walter C
Director
0 $0 102,758
(Direct)
View
2020-09-11
Option Award
2020-09-15
8:18 pm
N/A
2030-09-11
Novus Therapeutics Inc. NVUS LYONS GARY A
Director
1,167 $0 1,167
(Direct)
View
2020-09-11
Option Award
2020-09-15
8:13 pm
N/A
2030-09-11
Novus Therapeutics Inc. NVUS Kuwahara Jon
See Remarks
2,145 $0 2,145
(Direct)
View
2020-09-11
Option Award
2020-09-15
8:12 pm
N/A
2020-09-11
Novus Therapeutics Inc. NVUS Gros David-Alexandre C
CEO
18,278 $0 18,278
(Direct)
View
2020-09-11
Option Award
2020-09-15
8:10 pm
N/A
2030-09-11
Novus Therapeutics Inc. NVUS Katkin Keith
Director
5,907 $0 5,907
(Direct)
View
2020-09-11
Option Award
2020-09-15
8:10 pm
N/A
2030-09-11
Novus Therapeutics Inc. NVUS McBride John S.
Director
1,167 $0 1,167
(Direct)
View
2020-03-19
Option Award
2020-03-20
4:31 pm
N/A
2030-03-19
Novus Therapeutics Inc. NVUS FLESHER GREGORY J.
CEO
200,000 $0 200,000
(Direct)
View
2020-03-19
Option Award
2020-03-20
4:31 pm
N/A
2030-03-19
Novus Therapeutics Inc. NVUS TURKEL CATHERINE C.
President
100,000 $0 100,000
(Direct)
View
2020-03-19
Option Award
2020-03-20
4:30 pm
N/A
2030-03-19
Novus Therapeutics Inc. NVUS Kuwahara Jon
See Remarks
50,000 $0 50,000
(Direct)
View
2019-09-26
Option Award
2019-09-30
9:30 pm
N/A
2029-09-26
Novus Therapeutics Inc. NVUS Kuwahara Jon
See Remarks
60,000 $0 60,000
(Direct)
View
2019-09-26
Option Award
2019-09-30
9:30 pm
N/A
2029-09-26
Novus Therapeutics Inc. NVUS TURKEL CATHERINE C.
President
75,000 $0 75,000
(Direct)
View
Goto 0, 1, Next